---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018482"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:30:10.152520+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ensysce Biosciences believes it regains Nasdaq stockholders' equity compliance after warrant exercise

## Summary
- Company believes it now has at least $2.5M stockholders' equity, satisfying Nasdaq listing rule.
- February 2024 warrant exercise generated gross proceeds of ~$4.7M.
- Previously received Nasdaq extension to May 13, 2024 to evidence compliance.
- Awaiting Nasdaq formal confirmation of compliance status.

## SEC filing metadata
- accession: 0001493152-24-018482
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315224018482/0001493152-24-018482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224018482/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018482
- JSON: https://secwatch.observer/filing/0001493152-24-018482.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.